NewAmsterdam Pharma Co N.V. (NAMS) Form 8-K — Aug 14, 2026
NewAmsterdam Pharma Company N.V. appointed Robert W. Gunning, age 55, as its principal accounting officer on August 10, 2026. He succeeds Louise Kooij, whose departure from the role was previously announced and takes effect August 31, 2026.
Key figures
- Officer age
- 55
- Base salary usd
- 375000
- Rsu award shares
- 3200
- Stock option shares
- 14000
- Target bonus pct of base
- 30
Price after filing
1 day: 0.0%7 days: +3.3%30 days: -15.5%
Close on the filing date to close N calendar days later (from $26.98). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.